10-05-2018 03:46 PM CET - Health & Medicine

Diabetes Drug Therapy Market 2018 Global Research and Top Manufacturers: Abbott, MannKind Corporation, Bristol-Myers Squibb, Medtronic, AstraZeneca, Eli Lilly and Company, GSK, Sanofi, Novo Nordisk, and Novartis

Press release from: Research for Markets
PR Agency: Research for Markets
Diabetes Drug Therapy Market
Diabetes Drug Therapy Market

Report gives comprehensive analysis of the market structure along with forecast of the various segments and sub-segments of the Diabetes Drug Therapy Market. After studying key companies, the report focuses on the startups contributing towards the growth of the market. Possible mergers and acquisitions among the startups and key organizations are identified by the report's authors in the study.

The Worldwide Market For Diabetes Drug Therapy Is Expected To Grow At A CAGR Of Will Reach 10000 Million US$ In 2023, From 10000 Million US$ In 2017.

Diabetes is group of metabolic disorder, often referred as diabetes mellitus, results in high blood glucose levels. Body cells use glucose as a source of energy and insulin is important for the cells to absorb this glucose. When the body cells loose the capacity to respond to the insulin or body is not capable of producing sufficient insulin, it leads to an increase in blood glucose levels in the body. This condition is referred to as diabetes.

The Market Share Of The Three Is Largest Companies Accounted Of Global Market, Which Are:

· Abbott Laboratories

· Mannkind Corporation

· Bristol Myers Squibb

· Medtronic

· AstraZeneca

· Eli Lilly and Company

· GlaxoSmithKline

· Sanofi

· Novo Nordisk

· Novartis International AG

Get Free Sample Report @ www.researchformarkets.com/sample/global-diabetes-drug-th...

Depending on the cause of development, it is divided into three types, which includes type 1 diabetes (body loses the capacity of producing sufficient insulin), type 2 diabetes (most common and body cells do not respond to insulin) and gestational diabetes (occurs in pregnant women). Among these, type 2 diabetes is the most common type and affects over 90% of the global diabetic patients.

This report focuses on the Diabetes Drug Therapy in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Type, covers

· Glucagon-like peptide-1 (GLP-1) agonist

· Dipeptidyl-peptidase-4 (DPP-4) inhibitors

· Sodium glucose co-transporter 2 (SGLT2) inhibitors

· Insulin

· Others

Market Segment by Applications, can be divided into

· Gestational Diabetes

· Impaired Glucose Tolerance and Impaired Fasting Glycaemia

To Know More Details about Diabetes Drug Therapy Market @ www.researchformarkets.com/reports/global-diabetes-drug-t...

Table of Contents

Part 1. Exclusive Summary

Part 2. Methodology

Part 3. Introduction

Part 4. Competitive Landscape

Part 5. Market Dynamics

Part 6. Segmentation by Application

Part 7. Supply by Region

Part 8. Consumption Pattern

Part 9. Diabetes Drug Therapy Market Forecast

Part 10. Key Vendors

Part 11. Industry Activity

Part 12. Appendix

Key Reasons to Purchase

· To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.

· Assess the production processes, major issues, and solutions to mitigate the development risk.

· To understand the most affecting driving and restraining forces in the market and its impact in the global market.

· Learn about the market strategies that are being adopted by leading respective organizations.

· To understand the future outlook and prospects for the market.

· Besides the standard structure reports, we also provide custom research according to specific requirements.

Customization Options

• All segmentation provided above in this report is represented at country level and can be customized according to needs.

• All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization).

Inquiry Before Buying @ www.researchformarkets.com/inquiry/global-diabetes-drug-t...


Mr. A Naidu

Research for Markets

Tel: +44 8000-4182-37 (UK)

Email: alan.naidu@researchformarkets.com

About Research for Markets:

Research for Markets indulges in detailed and diligent research on different markets, trends and emerging opportunities in the successive direction to cater to your business needs. We have established the pillars of our flourishing institute on the grounds of Credibility and Reliability. RFM delve into the markets across Asia Pacific, North America, South America, Europe, Middle East and Africa.

This release was published on openPR.
News-ID: 1284257 • Views: 360
More releasesMore releases

You can edit or delete your press release here: